Open Medical and FotoFinder have announced a new partnership that brings together innovative cloud technology and state-of-the-art skin imaging.
Open Medical’s digital transformation solution, Pathpoint eDerma, in combination with FotoFinder’s Automatic Total Body Mapping technology, will enable dermatologists worldwide to access high-quality dermoscopic images and provide prompt specialised care regardless of location.
Michael Shenouda, commercial director at Open Medical, said:
“We are very excited to launch this new endeavour with FotoFinder, which will leverage our innovative digital solution eDerma and FotoFinder’s groundbreaking imaging devices to improve patient care.
“This is a new dimension in early skin cancer detection and we are proud to be collaborating with FotoFinder to transform skin cancer workflows and enhance the quality and access of care provided to patients.”
FotoFinder creates medical devices that capture high-resolution images of skin conditions, which can be used for diagnosis, progression monitoring, and treatment evaluation.
Their advanced skin mapping and analysis tools provide dermatologists with powerful algorithms to make more informed treatment decisions, demonstrating changes in skin conditions over time with astounding precision.
The clinically-coded Pathpoint eDerma digital transformation solution was developed in collaboration with dermatologists to improve care delivery, streamline departmental workflows, and enhance service coordination.
With eDerma, healthcare providers can manage multiple aspects of a patient’s journey through a centralised platform that includes referral capture, clinic and theatre planning workflows, remote patient monitoring, patient engagement, and digital consent.
As a cloud-based platform, it is accessible from anywhere and provides visibility of the end-to-end patient journey.
By synergising the two technologies, dermatologists will be able to view high-resolution skin images, deliver care to patients remotely, monitor patients over time, and track the progression of skin conditions from anywhere in the world.
This will improve patient access to care, reduce waiting times, and enable early detection and treatment of potentially cancerous skin lesions.
Additionally, the collaboration between Open Medical and FotoFinder will support future research efforts in artificial intelligence, using Pathpoint’s functionalities and FotoFinder’s dermatological image databases.
Dr Massey Tahmasebi, CEO at FotoFinder UK, said:
“FotoFinder UK is pleased to officially announce our new collaboration with Open Medical[…]
“It has been recognised that the majority of patient referrals have non-relevant skin lesions, and as a result, there is a substantial backlog of referrals with immediate demand to manage patients with skin cancers.
“Our goal is to optimise skin cancer diagnosis and management of skin lesions with potential benefits of FotoFinder Artificial Intelligence (AI) solution and Open Medical effective workflow.”
